UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.

17/11/2023 17/11/2023

When the trial ends: The case for post-trial provisions in clinical psychedelic research

We show how conceiving of post-trial provision as an integral site of the research process, and an appropriate destination for research funding, will serve to develop the infrastructure necessary for the post-legalisation psychedelic medicine ecosystem.

07/10/2023 07/10/2023

History repeating: guidelines to address common problems in psychedelic science

We show how these problems threaten internal validity (treatment effects are due to factors unrelated to the treatment), external validity (lack of generalizability), construct validity (unclear working mechanism), or statistical conclusion validity (conclusions do not follow from the data and methods).

23/04/2023 23/04/2023

Emerging challenges for psychedelic therapy

We aim to frame these psychedelic research challenges with 4 fundamental questions.

22/10/2022 22/10/2022

The expanding scope of psychedelics as medicines

I want to give you a peek into the underside of the iceberg of psychedelic research. Let’s step away from the headlines, broaden our scope, and dive into the frontier of this field.

17/09/2022 17/09/2022

The use of psychedelics in the treatment of medical conditions: An analysis of currently registered psychedelics studies in the American drug trial registry

There appears to be a recent uptrend in registered clinical trials studying psychedelics, which is similar to the recent increase in overall trials registered.